Dr. Danilov earned his medical degree and PhD in Physiology in Russia. He is a physician-scientist with background in molecular biology and oncologic drug development and expertise in cancer cell signaling. He leads an independent research program in hematologic malignancies which bridges the understanding of B-cell biology with early clinical evaluation of novel therapeutics.